Evidence map›Paper›PMID 24414067›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2014

Altered reactivity of resistance vasculature contributes to hypertension in elastin insufficiency.

Patrick Osei-Owusu, Russell H Knutsen, Beth A Kozel, Hans H Dietrich, Kendall J Blumer, Robert P Mecham

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Mitochondrial fission inhibition protects against hypertension induced by angiotensin II.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Patrick Osei-OwusuDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri;
Russell H Knutsen
Beth A Kozel
Hans H Dietrich
Kendall J Blumer
Robert P Mecham
Washington University in St. Louis · USDrexel University · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
ZINC AND ISCHEMIC BRAIN INJURYP01NS032636 · NINDS · WASHINGTON UNIVERSITY · PI YAMADA, KELVIN A · 1995 to 2010
$13.2M
MECHANISM &REGULATION OF RECEPTOR G PROTEIN SIGNALINGR01GM044592 · NIGMS · WASHINGTON UNIVERSITY · PI BLUMER, KENDALL J · 1990 to 2017
$7.5M
Training of the Pediatric Physician-ScientistT32HD043010 · NICHD · WASHINGTON UNIVERSITY · PI MARK E. LOWE · 2002 to 2026
$6.4M
RGS PROTEIN FUNCTION AND REGULATIONR01HL075632 · NHLBI · WASHINGTON UNIVERSITY · PI BLUMER, KENDALL J · 2005 to 2013
$4.5M
ASSEMBLY OF LUNG ELASTINR37HL053325 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 2000 to 2009
$4.1M
ASSEMBLY OF LUNG ELASTINR01HL053325 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 1995 to 2019
$3.6M
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIXR01HL105314 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P., WAGENSEIL, JESSICA · 2010 to 2018
$3.2M
ELASTIN IN VESSEL DEVELOPMENT & VASCULAR DISEASESR01HL074138 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 2004 to 2012
$3.0M
PROPAGATION OF VASOMOTOR RESPONSE IN BRAIN BLOOD VESSELSR01NS030555 · NINDS · WASHINGTON UNIVERSITY · PI DACEY, RALPH G · 1993 to 2008
$2.4M
RADIAL AND LONGITUDINAL MICROVASCULAR COMMUNICATIONR29HL057540 · NHLBI · WASHINGTON UNIVERSITY · PI DIETRICH, HANS H · 1997 to 2000
$102k
NHLBI NIH HHS HL-075632NHLBI NIH HHS HL-105314NHLBI NIH HHS HL-53325NHLBI NIH HHS HL-57540NHLBI NIH HHS HL-74138NHLBI NIH HHS R01 HL105314NICHD NIH HHS T32 HD043010NIDDK NIH HHS P30 DK020579NIGMS NIH HHS GM-445920NIGMS NIH HHS R01 GM044592NINDS NIH HHS NS-30555NINDS NIH HHS NS-32636
6 · The paper itself

Abstract

Elastin (Eln) insufficiency in mice and humans is associated with hypertension and altered structure and mechanical properties of large arteries. However, it is not known to what extent functional or structural changes in resistance arteries contribute to the elevated blood pressure that is characteristic of Eln insufficiency. Here, we investigated how Eln insufficiency affects the structure and function of the resistance vasculature. A functional profile of resistance vasculature in Eln(+/-) mice was generated by assessing small mesenteric artery (MA) contractile and vasodilatory responses to vasoactive agents. We found that Eln haploinsufficiency had a modest effect on phenylephrine-induced vasoconstriction, whereas ANG II-evoked vasoconstriction was markedly increased. Blockade of ANG II type 2 receptors with PD-123319 or modulation of Rho kinase activity with the inhibitor Y-27632 attenuated the augmented vasoconstriction, whereas acute Y-27632 administration normalized blood pressure in Eln(+/-) mice. Sodium nitroprusside- and isoproterenol-induced vasodilatation were normal, whereas ACh-induced vasodilatation was severely impaired in Eln(+/-) MAs. Histologically, the number of smooth muscle layers did not change in Eln(+/-) MAs; however, an additional discontinuous layer of Eln appeared between the smooth muscle layers that was absent in wild-type arteries. We conclude that high blood pressure arising from Eln insufficiency is due partly to permanent changes in vascular tone as a result of increased sensitivity of the resistance vasculature to circulating ANG II and to impaired vasodilatory mechanisms arising from endothelial dysfunction characterized by impaired endothelium-dependent vasodilatation. Eln insufficiency causes augmented ANG II-induced vasoconstriction in part through a novel mechanism that facilitates contraction evoked by ANG II type 2 receptors and altered G protein signaling.

Indexed as

Arterial PressureVasoconstrictionVasodilationAngiotensin IIAnimalsCalciumDisease Models, AnimalDose-Response Relationship, DrugElastinEndothelium, VascularGenetic Predisposition to DiseaseHaploinsufficiencyHemizygoteHypertensionMaleMesenteric ArteriesAngiotensin IICalciumElastinProtein Kinase InhibitorsReceptor, Angiotensin, Type 2rho-Associated KinasesVasoconstrictor AgentsVasodilator Agentsangiotensin receptorselastin haploinsufficiencyG proteinG protein-coupled receptorsresistance arteriesvasoconstriction

Identifiers

PMID24414067
PMCPMC3949062
OpenAlexW2130896405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.